Powered by TradingView
ZYNE
Zynerba Pharmaceuticals, Inc.
Exchange: NASDAQ
Zynerba Pharmaceuticals develops synthetic cannabinoid based medicines to help treat a wide-range of needs. Currently, the company has a synthetic gel in phase 2 of clinical development for epilepsy.
Search for ZYNE news >>Do you represent Zynerba Pharmaceuticals, Inc.? Get in touch to claim your listing.
Contact Info:
-
Website:
-
Phone:
-
Headquarters:
80 West Lancaster Avenue Suite 300, Devon, PA United States
More Cannabis Stocks
Learn about other publicly-traded cannabis & hemp companies:
APHQF
Aphria, Inc.
OTCMKTS
CVSI
CV Sciences, Inc.
OTCMKTS
CGRW
Cannagrow Holdings, Inc.
OTCMKTS
GBLX
GBSciences, Inc.
OTCMKTS
CHOOF
Choom Holdings, Inc.
OTCMKTS
IIPR
Innovative Industrial Properties, Inc.
NYSE